Effect of Silver Diamine Fluoride on Local Anesthesia in Hypomineralized Molars

Sponsor
University of Michigan (Other)
Overall Status
Recruiting
CT.gov ID
NCT05964387
Collaborator
(none)
50
1
2
12.6
4

Study Details

Study Description

Brief Summary

The purpose of this randomized, controlled clinical study is to evaluate if application of 38% SDF increases the efficacy of local anesthesia during operative dentistry on permanent molars affected by molar-incisor hypoplasia (MIH). The goal is to determine if pre-operative application of SDF results in improved local anesthesia and decrease in procedural pain in MIH affected teeth, thereby addressing an important challenge in routine clinical practice and contributing to the development of a treatment protocol for MIH affected molars.

Condition or Disease Intervention/Treatment Phase
  • Device: SDF
  • Device: Placebo
N/A

Detailed Description

Molar incisor hypomineralization (MIH) is defined as a qualitative enamel defect of unknown etiology that affects one or more permanent molars and may also affect the permanent incisors. Clinically, the presentation of MIH depends on severity: lesions can range from mild, with white to yellow-brown discolored opacities, to severe, with extensive post-eruptive enamel breakdown and atypical caries. Hypomineralized enamel has increased porosity with reduced mineral content, which promotes bacteria penetration, resulting in development and rapid progression of dental caries and subclinical chronic pulp inflammation.

Treatment of teeth affected by MIH pose a clinical challenge due to several reasons. Post-eruptive breakdown of inadequately formed enamel exposes underlying dentin, resulting in hypersensitivity to hot and cold temperatures, air, and water. This increased tooth sensitivity leads to poor oral hygiene and subsequent plaque retention. Additionally, chronic subclinical inflammation of the pulp hypersensitizes the gamma-aminobutyric acid (GABA) receptors in the pulp nerve tissue and reduces the pain threshold in these teeth. This weakens the action of local anesthetics making it difficult to achieve adequate pain control during dental treatment.

Recently, 38% silver diamine fluoride (SDF), a solution of silver fluoride and ammonium ions, has been shown to be effective in tooth desensitization by blocking dentinal tubules and promoting remineralization of demineralized tooth structure. SDF can be useful in managing symptomatic MIH-affected teeth by stimulating the production of calcium fluoride and silver iodide, both of which are able to occlude dentinal tubules and reduce their patency.

The purpose of this randomized, controlled clinical study is to evaluate the efficacy of local anesthesia on MIH-affected molars treated with 38% SDF. The goal is to determine if pre-operative application of SDF results in improved local anesthesia and decrease in procedural pain in MIH affected teeth, thereby addressing an important challenge in routine clinical practice and contributing to the development of a treatment protocol for MIH affected molars.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Subjects randomized for application of 38% silver diamine fluoride or placebo on hypomineralized permanent molar two weeks before operative dentistry.Subjects randomized for application of 38% silver diamine fluoride or placebo on hypomineralized permanent molar two weeks before operative dentistry.
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Masking Description:
The subject, care provider/outcomes assessor, and investigator will be blinded to which arm the tooth is randomized.
Primary Purpose:
Treatment
Official Title:
Effect of Silver Diamine Fluoride on Local Anesthesia Efficacy in Molar Incisor Hypomineralization-affected Molars in Children: A Randomized Clinical Trial
Actual Study Start Date :
Jun 12, 2023
Anticipated Primary Completion Date :
Jul 1, 2024
Anticipated Study Completion Date :
Jul 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: SDF

38% SDF applied to hypomineralized permanent molar two weeks prior to restorative care of the tooth.

Device: SDF
38% SDF will be applied to the hypoplastic area of the enrolled first permanent molar.
Other Names:
  • 2% lidocaine with 1:100,000 epinephrine
  • Placebo Comparator: Placebo

    Inert liquid (colored water) applied to hypomineralized permanent molar two weeks prior to restorative care of the tooth.

    Device: Placebo
    An inert liquid will be applied to the hypoplastic area of the enrolled first permanent molar.

    Outcome Measures

    Primary Outcome Measures

    1. Sixou and Barbosa-Rogier scale for local anesthesia efficacy [At least two weeks following application of SDF or placebo on the enrolled tooth]

      Four point scale evaluating efficacy of local anesthesia

    Secondary Outcome Measures

    1. Schiff Cold Air Sensitivity Scale [At least two weeks following application of SDF or placebo on the enrolled tooth]

      Four point scale evaluating tooth sensitivity to cold

    Other Outcome Measures

    1. Face, Legs, Activity, Cry, Consolability (FLACC) Scale [At least two weeks following application of SDF or placebo on the enrolled tooth]

      Three point scale evaluating five components of behavior and expression of discomfort in children

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    6 Years to 11 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • At least one hypomineralized first permanent molar with a primary cavitated caries lesion(s) or a cavitated tooth defect requiring restorative dental care with local anesthesia

    • American Society of Anesthesiologists (ASA) Physical Status Classification I or II (healthy children or those with mild systemic disease)

    • English speaking

    • Subjects for which basic behavior guidance (non-pharmacological or nitrous oxide/oxygen) is indicated

    Exclusion Criteria:
    • Teeth with irreversible pulpitis and pulp necrosis

    • Patients requiring advanced behavior management such as moderate sedation, general anesthesia, and/or active or passive restraint

    • Inability of the child to cooperate due to special needs or other conditions

    • Allergy to SDF, local anesthetic or other material component

    • Subjects with ulcerative gingivitis or stomatitis

    • Subjects with known sensitivity to silver or other heavy-metal ions

    • Subjects showing abnormal skin sensitization in daily circumstances

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Michigan Ann Arbor Michigan United States 48109

    Sponsors and Collaborators

    • University of Michigan

    Investigators

    • Principal Investigator: James Boynton, DDS, University of Michigan

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    James R. Boynton, Clinical Professor, University of Michigan
    ClinicalTrials.gov Identifier:
    NCT05964387
    Other Study ID Numbers:
    • HUM00228059
    First Posted:
    Jul 27, 2023
    Last Update Posted:
    Jul 27, 2023
    Last Verified:
    Jul 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    Yes
    Product Manufactured in and Exported from the U.S.:
    No
    Keywords provided by James R. Boynton, Clinical Professor, University of Michigan
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 27, 2023